Aerie Pharmaceuticals, Inc. Elects Dr. Gerald D. Cagle to the Company’s Board of Directors

Published: Sep 06, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Aerie Pharmaceuticals, Inc., announced today that Gerald D. Cagle, Ph.D., has been elected to the Company’s Board of Directors, effective immediately. Dr. Cagle brings more than three decades of experience in ophthalmological product development, including as Senior Vice President of R&D and Chief Scientific Officer at Alcon Laboratories, Inc. With the election of Dr. Cagle to Aerie’s Board, the Company’s directors number nine.

Help employers find you! Check out all the jobs and post your resume.

Back to news